The Effects of the Novel Unloading Device "HEPHAISTOS" on Bone, Muscles and Vessels
- Conditions
- Muscle; Atrophy, General
- Interventions
- Device: Hephaistos unloading orthosis
- Registration Number
- NCT03086187
- Lead Sponsor
- DLR German Aerospace Center
- Brief Summary
11 healthy men used the HEPHAISTOS unloading orthosis in an ambulatory 8 week intervention study.
It greatly reduces calf muscle forces without reducing ground reaction forces.
- Detailed Description
The 56day unloading intervention with HEPHAISTOS had the following key objectives:
1. Primary objective: Assessment and evaluation of bone adaptation.
2. Secondary objective: Assessment and evaluation of functional and structural muscular adaptations.
3. Third objective: Assessment and evaluation of functional and structural vascular adaptations.
4. Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 11
- male
- age: 20-45
- BMI: 20-30
- smoking
- professional sports men
- diabetes
- rheumatism
- muscle and joint disease
- bone fractures within 12 months prior to the study
- cruciate ligament rupture within 10 years prior to the study
- metal implants
- participation in any other clinical study within 2 months prior to the study haemophilia
- any blood vessel disease
- epilepsy
- claustrophobia
- herniated disk
- cardiac pulse generator
- drug or alcohol abuse
- hyperlipidaemia
- kidney disease
- hyperhomocysteaemia
- hyper/hypouricemia
- hyper/hypocalcaemia
- anaemia
- vitamin d deficit
- chronical back pain
- deficient certificate of good conduct
- achilles tendon injury
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Hephaistos unloading orthosis Hephaistos unloading orthosis Hephaistos unloading orthosis: Calf muscle unloading: The 11 male subjects had to wear a novel orthosis for 8 weeks, which greatly reduces plantarflexor forces during gait.
- Primary Outcome Measures
Name Time Method Bone density as measured with pQCT At baseline and up to 12 months after the immobilization phase Change from baseline to 14 days after immobilization phase
- Secondary Outcome Measures
Name Time Method Structural and functional parameters of arterial adaptation At baseline and up to 12 months after the immobilization phase Change in flow-mediated dilation
Trial Locations
- Locations (1)
German Aerospace Center
🇩🇪Cologne, North Rine Westphalia, Germany